CD300ld blockade overcomes PMN-MDSC-mediated vaccine resistance in advanced tumors
Background While cancer vaccines have demonstrated promising clinical potential, their therapeutic efficacy against advanced tumors remains suboptimal, highlighting the critical need to elucidate resistance mechanisms and develop targeted solutions. We previously developed a stimulator of interferon...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
2026-01-01
|
| シリーズ: | Journal for ImmunoTherapy of Cancer |
| オンライン･アクセス: | https://jitc.bmj.com/content/14/1/e013336.full |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|